Nutralife Biosciences Inc - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS

Ticker Exchange SIC # Website Latest Ticker
NLBS Over the counter 2833 https://nutralifebiosciences.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Nutralife Biosciences Inc

NutraLife Biosciences (OTC: NLBS) Releases Q4 2022 Shareholder Update and Announces the Acquisition of Healthcare Concierges USA - Mar 1st, 2023 5:53 pm
NutraLife Biosciences (OTC: NLBS) Releases Q4 2022 Shareholder Update - Nov 17th, 2022 4:48 pm
NutraLife Biosciences Launches a Clinically Tested Focus Stimulant Under a Master Distribution Agreement - Oct 27th, 2022 12:00 pm
Nutralife Biosciences Executes a Joint Venture Agreement With Emergent Health Corporation for the Co-Production, Co-Marketing, and Distribution of Emergent’s Line of Regenerative, and Other Health-Related Nutraceutical, Skincare and Pet Pro - Jul 8th, 2022 12:30 pm
NutraLife Biosciences Inc. Engages CFN Media to Reach, Attract Retail, Accredited & Institutional Investors - Jun 15th, 2022 1:00 pm